
1. hepatology. 1993 nov;18(5):1055-60.

peripheral-blood mononuclear cell responses recombinant hepatitis c virus
antigens patients chronic hepatitis c.

schupper h(1), hayashi p, scheffel j, aceituno s, paglieroni t, holland pv,
zeldis jb.

author information: 
(1)university california, davis, medical center, sacramento 95817.

peripheral blood mononuclear cell proliferative responses vitro recombinant
yeast escherichia coli hepatitis c virus fusion proteins evaluated 20 
patients chronic hepatitis c reactive antibody hepatitis c
virus (on enzyme immunoassay, version 2.0, four-antigen recombinant
immunoblot assay). twenty age-matched, healthy individuals negative antibody 
to hepatitis c virus used control group. peripheral-blood mononuclear
cells chronic hepatitis c patients antibodies hepatitis c virus 
antigens c22 c100-3 proliferated vitro response corresponding
recombinant hepatitis c virus fusion protein. peripheral-blood mononuclear cells 
from 75% patients infected hepatitis c virus proliferated response 
cytidine monophosphate-keto-3-deoxyoctulosonic acid-core recombinant antigen 
there proliferative response cytidine
monophosphate-keto-3-deoxyoctulosonic acid-ef (derived ns5 region). 
hepatitis c virus-infected patients 33c antibody, peripheral-blood
mononuclear cells 9 14 (64%) proliferated vitro response to
33c. ninety-five percent hepatitis c virus-infected patients had
peripheral-blood mononuclear cells proliferated response least one 
recombinant hepatitis c virus fusion protein. numbers percentages cd3 
t cells, cd19 b cells natural killer cells patients chronic
hepatitis c virus infection differ healthy control
group. however, number non-major histocompatibility complex-restricted
cytotoxic cells (cd3-positive, cd56-positive, cd16-positive) increased in
patients chronic hepatitis c virus infection (p < 0.05).


pmid: 7693570  [indexed medline]

